ELITE PHARMACEUTICALS INC /NV/ Quarterly Inventory, Net in USD from Q1 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly Inventory, Net history and growth rate from Q1 2011 to Q4 2024.
  • Elite Pharmaceuticals Inc /Nv/ Inventory, Net for the quarter ending December 31, 2024 was $20.2M, a 40.7% increase year-over-year.
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $20.2M +$5.83M +40.7% Dec 31, 2024 10-Q 2025-02-13
Q3 2024 $14.2M -$1.06M -6.96% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $13.8M +$2.66M +23.8% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $12.9M +$3.38M +35.4% Mar 31, 2024 10-Q 2025-02-13
Q4 2023 $14.3M +$5.72M +66.5% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $15.2M +$7.76M +104% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $11.2M +$3.55M +46.6% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $9.55M +$2.81M +41.7% Mar 31, 2023 10-K 2024-07-01
Q4 2022 $8.6M +$1.91M +28.5% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $7.47M +$923K +14.1% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $7.62M +$914K +13.6% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $6.74M +$1.73M +34.5% Mar 31, 2022 10-K 2023-06-29
Q4 2021 $6.69M +$1.89M +39.4% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $6.55M +$2.08M +46.7% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $6.7M +$1.14M +20.4% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $5.01M +$870K +21% Mar 31, 2021 10-K 2022-06-29
Q4 2020 $4.8M +$992K +26% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $4.46M +$730K +19.6% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $5.57M +$1.03M +22.6% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $4.14M -$373K -8.27% Mar 31, 2020 10-K 2021-06-14
Q4 2019 $3.81M -$382K -9.11% Dec 31, 2019 10-Q 2020-02-10
Q3 2019 $3.73M -$754K -16.8% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $4.54M +$400K +9.65% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $4.52M -$382K -7.81% Mar 31, 2019 10-K 2020-06-30
Q4 2018 $4.19M -$1.11M -20.9% Dec 31, 2018 10-Q 2019-02-11
Q3 2018 $4.49M -$1.22M -21.4% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $4.14M -$1.75M -29.7% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $4.9M -$1.52M -23.7% Mar 31, 2018 10-K 2019-06-21
Q4 2017 $5.3M -$730K -12.1% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 $5.71M +$73.3K +1.3% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $5.89M +$2.15M +57.7% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $6.42M +$3.12M +94.8% Mar 31, 2017 10-K 2018-06-14
Q4 2016 $6.03M +$2.85M +89.5% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 $5.64M +$2.28M +68.1% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $3.74M +$872K +30.5% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $3.29M +$262K +8.63% Mar 31, 2016 10-K 2017-06-14
Q4 2015 $3.18M +$318K +11.1% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $3.35M +$830K +32.9% Sep 30, 2015 10-Q/A 2015-12-30
Q2 2015 $2.86M +$337K +13.4% Jun 30, 2015 10-Q/A 2015-12-30
Q1 2015 $3.03M +$1.1M +56.9% Mar 31, 2015 10-K 2016-06-15
Q4 2014 $2.86M +$1.33M +87% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 $2.52M +$804K +46.8% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 $2.53M +$1.59M +169% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $1.93M +$574K +42.3% Mar 31, 2014 10-K 2015-06-15
Q4 2013 $1.53M +$547K +55.6% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 $1.72M +$1.24M +258% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $939K +$576K +159% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $1.36M +$1.05M +345% Mar 31, 2013 10-K 2014-06-30
Q4 2012 $984K +$553K +128% Dec 31, 2012 10-Q 2013-02-14
Q3 2012 $481K +$98.5K +25.8% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $363K +$50.9K +16.3% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $305K -$311K -50.5% Mar 31, 2012 10-K 2013-06-21
Q4 2011 $431K Dec 31, 2011 10-Q 2012-02-14
Q3 2011 $382K Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $312K Jun 30, 2011 10-Q/A 2011-08-19
Q1 2011 $616K Mar 31, 2011 10-K 2012-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.